Literature DB >> 17803342

Age and gender biases in secondary prevention of coronary heart disease in a Finnish university hospital setting.

Sanna-Maria Michou1, Mika Kähönen, Terho Lehtimäki, Kjell Nikus, Jari Viik, Kari Niemelä, Janne Kallio, Rami Lehtinen, Tiit Kööbi, Väinö Turjanmaa, Tuomo Nieminen.   

Abstract

BACKGROUND AND OBJECTIVES: Several studies have shown that treatment of coronary heart disease (CHD) does not meet the goals set in recommendations. The aim of this study was to investigate the adequacy of CHD drug treatment and secondary prevention measures, particularly with respect to age and gender biases, in a Finnish university hospital setting.
METHODS: The participant pool consisted of patients in FINCAVAS (Finnish Cardiovascular Study), which is a cohort study recruiting consecutive patients performing a clinical exercise test at Tampere University Hospital, Tampere, Finland. 802 patients (581 men, 221 women) with a prior diagnosis of CHD recruited between October 2001 and December 2004 were included in the analysis.
RESULTS: Only roughly 12% of both men and women had an optimal risk factor profile. High blood pressure and hypercholesterolaemia were more common in women than in men, whereas smoking was more frequent among men. Men used ACE inhibitors (32.9% vs 20.4%, respectively), beta-adrenoceptor antagonists (80.8% vs 68.3%, respectively) and aspirin (acetylsalicylic acid) [69.7% vs 58.8%, respectively] more frequently than women, but the frequency of use of these medications was also not at the recommended levels in men. Risk factor control is poorer in older than younger age groups.
CONCLUSIONS: CHD patients, particularly women, who performed an exercise stress test in a university hospital are suboptimally treated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803342     DOI: 10.2165/00044011-200727100-00002

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  23 in total

1.  Efficacy of treating hypertension in women.

Authors:  A Quan; K Kerlikowske; F Gueyffier; J P Boissel
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

2.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

3.  Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.

Authors:  R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

4.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

5.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

Authors: 
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

6.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors:  T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

7.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

8.  Blood pressure is insufficiently controlled in European patients with established coronary heart disease.

Authors:  Eric Boersma; Ulrich Keil; Dirk De Bacquer; Guy De Backer; Kalevi Pyörälä; Don Poldermans; Cristiana Leprotti; Lorenza Pilotto; Esther de Swart; Jaap W Deckers; Jan Heidrich; Susana Sans; Kornelia Kotseva; David Wood; Giovanni B Ambrosio
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

Review 9.  Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention.

Authors:  F E Kuhn; C E Rackley
Journal:  Arch Intern Med       Date:  1993-12-13

10.  Medical treatment and secondary prevention of coronary heart disease in general practice in Iceland.

Authors:  Emil L Sigurdsson; Jón Steinar Jónsson; Gudmundur Thorgeirsson
Journal:  Scand J Prim Health Care       Date:  2002-03       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.